The relative potency of some  -adrenoreceptor agonists on isolated human vein.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D002082:Butylamines / Q000494:pharmacology; D002396:Catechols / Q000494:pharmacology; D004338:Drug Combinations; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D000432:Methanol / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012501:Saphenous Vein / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002082:Butylamines; D002396:Catechols; D004338:Drug Combinations; D010627:Phenethylamines; D010880:Piperidines; D011437:Propylamines; D013566:Sympathomimetics; D011433:Propranolol; D007545:Isoproterenol; D000432:Methanol